The SPR Gene Dystonia DOPA-Responsive Autosomal Recessive Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SPR gene that are known to cause DOPA-responsive dystonia. This condition is a rare, inherited neurological disorder characterized by muscle contractions leading to repetitive movements or abnormal postures. These symptoms are notably responsive to treatment with DOPA, a precursor to dopamine, which is a neurotransmitter involved in controlling movement. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the SPR gene, which plays a critical role in dopamine biosynthesis. Identifying these mutations can confirm a diagnosis of DOPA-responsive dystonia, enabling healthcare providers to recommend the most effective treatment strategies. Conducted at DNA Labs UAE, this genetic test is a vital resource for individuals experiencing symptoms of dystonia seeking a definitive diagnosis and tailored treatment plan.
The TIMM8A gene dystonia-deafness syndrome, also known as Mohr-Tranebjaerg syndrome, is a rare genetic disorder characterized by progressive hearing loss, dystonia, visual impairment, and neurological decline. The condition is inherited in an X-linked recessive pattern, affecting primarily males, though female carriers may exhibit some symptoms.
To diagnose this condition, a specific genetic test targeting the TIMM8A gene can be conducted. DNA Labs UAE offers this specialized test, designed to detect mutations in the TIMM8A gene that are responsible for the syndrome. The test is crucial for accurate diagnosis, enabling early intervention and management strategies to alleviate symptoms and improve quality of life for affected individuals.
The cost of the TIMM8A gene dystonia-deafness syndrome genetic test at DNA Labs UAE is 4400 AED. This price includes the genetic analysis and a comprehensive report, which provides detailed insights into the individual's genetic makeup concerning the TIMM8A gene. The test is conducted with a high level of accuracy, using advanced genomic technologies to ensure reliable results. Families with a history of the syndrome or individuals showing symptoms are encouraged to consider this test for a definitive diagnosis and to inform potential treatment paths.
The PRRT2 Gene DYT10 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the PRRT2 gene, which are linked to DYT10 (also known as Paroxysmal Kinesigenic Dyskinesia or PKD). This condition is characterized by sudden, brief, involuntary movements or spasms triggered by sudden movements. The test is particularly important for individuals showing symptoms of PKD or those with a family history of the condition, as it can provide a definitive diagnosis and guide treatment and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the PRRT2 Gene DYT10 Genetic Test involves collecting a DNA sample, typically through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing techniques to detect any mutations in the PRRT2 gene that are indicative of DYT10.
The cost of the test is 4400 AED, which reflects the comprehensive nature of the genetic analysis and the expertise required to interpret the results. While the price may seem high, the value of a precise diagnosis cannot be understated, as it opens the door to targeted treatments and interventions that can significantly improve the quality of life for individuals affected by this condition.
Overall, the PRRT2 Gene DYT10 Genetic Test is a crucial tool in the diagnosis and management of Paroxysmal Kinesigenic Dyskinesia, providing patients and their families with the answers they need to navigate this challenging condition.
The SGCE Gene DYT11 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the SGCE gene, which are implicated in the development of Myoclonus-Dystonia (M-D), a neurological disorder characterized by rapid, involuntary muscle jerking (myoclonus) and dystonia, which involves abnormal muscle postures. This condition is often inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder, though reduced penetrance is observed, meaning not all individuals with the mutation will exhibit symptoms.
DNA Labs UAE offers this comprehensive genetic test to individuals who are showing symptoms of Myoclonus-Dystonia or have a family history of the disorder, providing a crucial tool for accurate diagnosis and subsequent management. By analyzing the patient's DNA for specific mutations in the SGCE gene, healthcare providers can confirm the diagnosis, understand the risk of passing the condition to offspring, and tailor treatment plans to manage symptoms effectively.
The cost of the SGCE Gene DYT11 Genetic Test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise required to perform this intricate analysis. This investment in health allows for a proactive approach in managing the condition, potentially improving the quality of life for those affected by Myoclonus-Dystonia.
The SLC2A1 gene, also known as the solute carrier family 2 member 1 gene, is crucial in the human body for the transport of glucose across the blood-brain barrier. Mutations in this gene are associated with a rare neurological disorder known as DYT18, also referred to as GLUT1 deficiency syndrome. This condition can lead to various symptoms including seizures, movement disorders, and developmental delays.
The DYT18 genetic test is a specialized diagnostic tool designed to detect mutations in the SLC2A1 gene, helping in the diagnosis of GLUT1 deficiency syndrome. This test is essential for individuals showing symptoms of the disorder, as an accurate diagnosis can lead to appropriate treatment and management strategies, including dietary modifications that can significantly improve symptoms.
In the UAE, DNA Labs UAE offers the SLC2A1 gene DYT18 genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with advanced genetic testing technology and staffed by professionals with expertise in genetic diagnostics, ensuring accurate and reliable results. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the SLC2A1 gene.
This test is an important step for patients and their families in understanding and managing GLUT1 deficiency syndrome, providing them with the information needed to make informed decisions about their health care.
The HPCA Gene DYT2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the HPCA gene, which are associated with DYT2 early-onset dystonia. DYT2 dystonia is a rare genetic disorder characterized by involuntary muscle contractions leading to abnormal postures and movements, typically manifesting in childhood or adolescence. This test plays a crucial role in confirming the diagnosis of DYT2 dystonia, enabling healthcare professionals to tailor treatment plans more effectively for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to detect any mutations in the HPCA gene. The accuracy and reliability of the results make it a valuable resource for families seeking answers about this challenging condition.
The cost of the HPCA Gene DYT2 Genetic Test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this analysis. Despite the cost, the test represents a significant step forward for individuals and families affected by DYT2 dystonia, offering hope for better management and understanding of the disorder.
The CACNA1B gene DYT23 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CACNA1B gene, which have been associated with DYT23, a specific form of dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, leading to repetitive movements or abnormal postures. The CACNA1B gene plays a crucial role in encoding the alpha-1B subunit of a type of voltage-dependent calcium channel, which is essential for the proper functioning of nerve cells. Mutations in this gene can disrupt normal neuronal communication, leading to the symptoms observed in DYT23 dystonia.
This genetic test is particularly important for individuals showing symptoms of dystonia without a clear cause, as it can provide a definitive diagnosis of DYT23, allowing for more targeted and effective treatment plans. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the CACNA1B gene.
The CACNA1B gene DYT23 genetic test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. By opting for this test at DNA Labs UAE, patients can expect reliable results, comprehensive support, and guidance on the implications of the test outcomes for their health and treatment options.
The ANO3 gene, associated with DYT24 dystonia, is a focus of genetic testing aimed at diagnosing this specific type of dystonia. DYT24 dystonia is a neurological disorder characterized by involuntary muscle contractions leading to abnormal postures and movements. The condition is attributed to mutations in the ANO3 gene, which plays a crucial role in the normal functioning of the nervous system.
DNA Labs UAE offers a comprehensive genetic test targeting the ANO3 gene to identify mutations that may lead to DYT24 dystonia. This test is essential for individuals exhibiting symptoms of dystonia or those with a family history of the condition, as it provides a definitive diagnosis, enabling targeted treatment and management strategies.
The cost of the ANO3 gene DYT24 genetic test at DNA Labs UAE is 4400 AED. This investment covers the meticulous process of analyzing the gene to detect any mutations accurately. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of dystonia, facilitating personalized medicine approaches and potentially improving the quality of life for those affected by the condition.
The GNAL Gene DYT25 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the GNAL gene, which are associated with DYT25 dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, resulting in twisting and repetitive movements or abnormal postures. The GNAL gene plays a crucial role in the proper functioning of the dopaminergic pathways in the brain, which are vital for controlling movement.
This genetic test is particularly important for individuals displaying symptoms of dystonia or those with a family history of the condition, as it can provide definitive confirmation of the DYT25 variant. Early diagnosis through genetic testing can lead to more targeted and effective management of the disorder, potentially improving the quality of life for affected individuals.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the GNAL Gene DYT25 Genetic Test is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect the presence of mutations in the GNAL gene.
Choosing DNA Labs UAE for this test ensures that patients receive accurate and reliable results, thanks to the lab's state-of-the-art technology and experienced genetic specialists. With these insights, healthcare providers can devise a more personalized approach to the treatment and management of DYT25 dystonia, ultimately enhancing patient care.
The KCTD17 Gene DYT26 Myoclonic Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the KCTD17 gene, which have been associated with DYT26 myoclonic dystonia, a rare genetic disorder. This condition is characterized by quick, involuntary muscle contractions (myoclonus) and, in some cases, dystonia, which involves abnormal muscle tone leading to repetitive movements or abnormal postures. The test is particularly crucial for individuals showing symptoms of myoclonic dystonia or those with a family history of the disorder, as it can provide definitive genetic evidence of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The sample is then analyzed for specific mutations in the KCTD17 gene that are known to cause DYT26 myoclonic dystonia. The outcome of this test can aid in the accurate diagnosis of the condition, which is essential for managing symptoms and improving the quality of life for affected individuals.
The cost of the KCTD17 Gene DYT26 Myoclonic Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test and the sophisticated technology and expertise required to accurately identify mutations in the KCTD17 gene. Given the complexity of genetic disorders and the significant impact a definitive diagnosis can have on treatment and management strategies, this test represents a critical step for patients and families dealing with the challenges of DYT26 myoclonic dystonia.
